跳至主要内容
临床试验/NCT01351298
NCT01351298已完成4 期

Intra-nasal Topical Local Anesthetic and Decongestant for Flexible Nasendoscopy in Children: a Randomised Double-blind Placebo Controlled Trial

Children's & Women's Health Centre of British Columbia1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
69
试验地点
1
主要终点
Pain score (self)

研究概览

简要总结

Flexible nasendoscopy involves passing a soft, thin, endoscope through the nose. This diagnostic procedure is often essential for assessment of a child by an Otolaryngologist in outpatients. The purpose of this randomized controlled double-blind study is to determine whether there is a difference in the degree of discomfort experienced by children undergoing flexible nasendoscopy, after receiving one of three different intranasal sprays: (A) placebo (isotonic saline solution), (B) decongestant (0.05% xylometazoline hydrochloride), or (C) decongestant with local anesthetic (0.05% xylometazoline hydrochloride with 1% lidocaine hydrochloride).

Null hypothesis: There is no difference in the degree of reported discomfort experienced (using a validated pediatric pain score) by children undergoing flexible nasendoscopy, after receiving either intra-nasal topical placebo, decongestant, or decongestant with local anesthetic.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Fully informed consent from parent/caregiver
  • Children aged 3 to 12 years
  • Children deemed to require flexible nasendoscopy as part of their assessment during a Pediatric Otolaryngology clinic visit

排除标准

  • Children who have previously undergone this procedure
  • Children with current upper respiratory tract infection
  • Children with known allergy to any of the trial medications

研究组 & 干预措施

Saline spray

Placebo Comparator

干预措施: Isotonic normal saline (Drug)

Decongestant

Experimental

干预措施: 0.05% xylometazoline hydrochloride (Drug)

Decongestant and local anesthetic

Experimental

干预措施: 0.05% xylometazoline hydrochloride with 1% lidocaine hydrochloride (Drug)

结局指标

主要结局

Pain score (self)

时间窗: Immediately post-nasendoscopy - same day as administration of nasal prep agent (day 1)

Self-reported Wong-Baker Faces Pain Score

次要结局

  • Pain score (proxy)(Immediately post-nasendoscopy- same day as administration of nasal prep agent (day 1))
  • Ease of nasendoscopy score(Immediately post-nasendoscopy- same day as administration of nasal prep agent (day 1))

研究者

发起方
Children's & Women's Health Centre of British Columbia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Neil Chadha

Clinical Assistant Professor

Children's & Women's Health Centre of British Columbia

研究点 (1)

Loading locations...

相似试验